Lucien (Luc) Sergile Jr. is a Quality Manager working for the Global Quality Auditing and Compliance Group at Eli Lilly and Company. In his 20 years of Monoclonal Anti-Body Production, Luc brings over 10 years (working for ImClone Systems and Eli Lilly) of experience in of GMP Biopharmaceutical Manufacturing and Validation. Luc was instrumental in the commissioning of two state of the art Biopharmaceutical production facilities for Eli Lilly in Branchburg, NJ.
For the last 11 years, Luc Sergile works with Corporate Quality Auditing for Lilly’s Global Quality Auditing and Compliance. Luc audits and monitors supply chain participants to support the global manufacturing of Lilly drug products and medical devices. Luc brings his expertise in GMP manufacturing and Supplier Oversight and knowledge to the table especially concerning data integrity when it comes to monitoring critical process parameters and ensuring the legitimacy and consistency of data with suppliers.
Luc also is a member of the IPEC Americas and Rx-360 and has helped author-auditing guides such as the IPEC GMP Audit Guide and the Rx-360 Data Integrity Audit Guide.